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Abstract
Macrophages are ubiquitously present innate immune cells in humans and ani-
mals belonging to both invertebrates and vertebrates. These cells were first recog-
nized by Elia Metchnikoff in 1882 in the larvae of starfish upon insertion of thorns
of tangerine tree and later in Daphnia magna or common water flea infected with
fungal spores as cells responsible for the process of phagocytosis of foreign particles.
Elia Metchnikoff received the Noble prize (Physiology and Medicine) for his
discovery and describing the process of phagocytosis in 1908. More than 130 years
have passed and different subtypes and roles of macrophages as innate immune
cells have been established by the researchers. In addition to their immunoregula-
tory role in immune homeostasis and pathogenic infection, they also play a crucial
role in the pathogenesis of sterile inflammatory conditions including autoimmunity,
obesity, and cancer. The present chapter describes the immunoregulatory role
of macrophages in the homeostasis and inflammatory diseases varying from
autoimmunity to metabolic diseases including obesity.
Keywords: macrophages, monocytes, innate immunity, inflammation, cytokines,
pathogens
1. Introduction
The innate immune system evolved to protect the host from invading foreign
pathogens, allergens, and different xenobiotics. The system comprises of both its
cellular and humoral (circulating complement proteins, defensins, certain cytokines
and chemokines secreted by innate immune cells) components. The innate immune
cells comprise of epithelial cells, endothelial cells (ECs), the granulocytes (i.e.
neutrophils, basophils, eosinophils, and mast cells (MCs), monocytes, macro-
phages, natural killer (NK) cells, dendritic cells (DCs), invariant NKT cells (iNKT
cells), γδT cells, and newly described innate immune T cells called mucosal invari-
ant T cells (MAIT) cells and innate lymphoid cells (ILCs) [1–9] (Figure 1). These
innate immune cells are crucial to maintain the immune homeostasis and regulate
adaptive immune system via acting as antigen presenting cells (APCs) along with
providing other signaling molecules/factors required in the effective adaptive
immune response in response to infection or other sterile chronic inflammatory
diseases including, allergy, autoimmunity, cancer, and metabolic diseases including
type 1 diabetes mellitus (T1DM), and obesity etc.
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Macrophages are type of innate immune cells that were first described by Elia
Metchnikoff in 1882 in larvae of starfish upon the insertion of thorns of tangerine
tree and later on in Daphnia magna or common water flea infected with fungal
spores as cells responsible for the process of phagocytosis of foreign particles. Elia
Metchnikoff received the Noble prize (Physiology and Medicine) for this discovery
in the year 1908. Thus macrophages are first innate immune cells described almost
130 years ago. The continuous development in the field of immunology has
established their role in various immunological and non-immunological processes
including embryonic development. Along with acting as potential phagocytic cells
involved in the phagocytosis of pathogens, xenobiotics, these cells also secrete
various cytokines, chemokines, and growth factors including TNF-α, TGF-β,
platelet-derived growth factor (PDGF), endothelial growth factor (EGF), and vas-
cular endothelial growth factor (VEGF) [10–12]. Thus macrophages are very potent
innate immune cells with diverse functions. The present chapter is intended to
describe the immunoregulatory role of macrophages in the maintenance of immune
homeostasis in the normal and disease stage.
2. Development of macrophages
Macrophages are the cells of the mononuclear phagocyte system (MPS) that was
previously considered as reticuloendothelial system (RES), a system associated with
the clearance and phagocytosis of dead cells [13]. They were included in the RES in
1924 to show their origin, residency, and renewal within RES. The RES was
renamed to the MPS system in 1968 by Ralf van Furth, Zanvil Cohn and colleagues
to distinguish them from polymorphonuclear leukocytes (PMNLs) or neutrophils
and to show that all macrophages originate via terminal differentiation blood
monocytes into different macrophages including pulmonary macrophages, liver
macrophages (or Kupffer cells), and peritoneal macrophages etc. [14, 15]. The MPS
comprises of monocytes, macrophages, and DCs involved in the maintenance of
tissue and organismal homeostasis, the pathogenesis of inflammation, cancer,
Figure 1.
Schematic representation of cellular components of innate immune system. Macrophages also comprise a very
important component of innate immune system along with other innate immune cells mentioned in the figure
and text.
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autoimmune diseases, infection and the generation of immune response associated
with the organ transplantation [16, 17].
Macrophages are developed during very early phase of embryogenesis called
primitive hematopoiesis occurring at embryonic day 6.5 [E6.5]-E8.5 from precursor
cells present in the extraembryonic yolk sac [18, 19]. The process of hematopoiesis
in line with ontogeny progresses towards fetal liver at the beginning of E10.5
and finally to the bone marrow in the adult animal including humans [18, 19]
(Figure 2). The primitive hematopoiesis occurring in the yolk sac of human
embryos comprises of about 70% macrophages of the total nucleated blood cells at
4 weeks of gestational age, while in mice embryos macrophages predominate in the
early stage of primitive hematopoiesis taking place in the yolk sac with the absence
Figure 2.
Schematic representation of production of macrophages in various organs throughout the mammalian (mouse
and human) development. For example, at embryonic day 6.5 [E6.5]-E8.5 macrophages develop in the
extraembryonic yolk sac from precursor cells, thereafter at E10.5 they develop in fetal liver, and in neonates and
adults they develop in bone marrow as mentioned in the text.
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of monocytic cells [20, 21]. From embryonic day 8.5 [E8.5]-E10.5, the aorta-gonad-
mesonephros give rise to hematopoietic stem cells (HSCs) giving birth to all
immune lineages [19]. The cells committed to become macrophages within the
mononuclear phagocyte lineage pass through morphologically-different but defined
developmental stages including common myeloid progenitors (CMPs), shared with
granulocytes giving rise to monoblasts, promonocytes and then monocytes that
migrate to different tissues [22]. The differentiation of HSCs or hematopoietic
progenitors (HPs) into different cell lineages including CMPs is governed by the
activation of highly regulated gene expression programs integrated by different
lineage-determining transcription factors (TFs) [23–25].
Pu.1 serves as an essential factor to reconstitute the myeloid cell lineage and for
the development of macrophages and monocytes in concentration-dependent man-
ner [24, 26, 27]. A high concentration of the TF called PU.1 promotes the macro-
phage development whereas a low level of PU.1 supports the B cell development
due to the presence of many low- and high-affinity PU.1 binding sites in the genome
[28, 29]. PU.1 is regulated by Runt-related transcription factor 1 (RUNX1) or Acute
myeloid leukemia 1 protein (AML1) or Core-binding factor subunit-alpha 2
(CBFA2) that are members of core-binding factor family of TFs [30]. The gene
Csf1r encoding the receptor for the cytokine IL-34 and monocyte-colony stimulat-
ing factor (MCSF) is one of the major targets of PU.1 in macrophage development
[31, 32] Cebp-α, -β, and -ε are important towards the development of different
myeloid cell types primarily including granulocytes, macrophages, and monocytes
[33, 34]. Irf8 also serves as a crucial TF for monocyte lineage along with DC lineage
by establishing monocyte- and DC-specific enhancers [35–38]. The TF called ZEB2
is essential for the maintenance of tissue-specific macrophages and its loss causes
tissue-specific changes in different macrophage populations including KCs and
their subsequent loss [39]. Thus these lineage-determining TFs, establish the central
macrophage program during the pre-macrophage stage. This core macrophage pro-
gram includes the expression of CX3CR1, pattern-recognition receptors (PRRs),
phagocytic receptors (PRs), FcγRs including FcγR1 or CD64 and various other
genes including Sirpα, Iba1,Mertk and Adgre1 (F4/80) expressed by almost all types
of macrophages [40, 41]. A bZip TF called MAFB (c-Maf) regulates the self-
renewal of macrophages and its induction is a specific and crucial determinant of
monocytic program in hematopoietic cells [42, 43].
There are two principal subtypes of monocytes in mice (Figure 3): (1) classical
Ly6chi monocytes (also called inflammatory monocytes expressing high levels of
CC-chemokine receptor 2 (CCR2) but low levels of CX3C-chemokine receptor 1
(CX3CR1)) that descend directly from Ly6c+ monocyte progenitors [44], and (2)
Ly6clow non-classical monocytes expressing high levels of CX3CR1 and low levels of
CCR2 that differentiate from Ly6chi monocytes through an Nr4a1 (nuclear receptor
subfamily 4 group A member 1 or Nur77)-dependent transcriptional program and
are less prevalent in blood [44–47]. The Ly6chi monocytes in mice represent
approximately 2–5% population of the circulating white blood cells (WBCs) in a
normal laboratory mouse without any infection and rapidly migrate towards the site
of infection and inflammation [48]. However the deficiency of CCR2 significantly
reduces the migration of Ly6chi monocytes at the site of infection and inflammation
indicating the importance of CCR2 in the trafficking of these monocytes [49–51].
These Ly6clow non-classical monocytes develop primarily to function within the
vasculature and patrol the vasculature by crawling over the resting endothelium
in an Lymphocyte function-associated antigen 1 (LFA-1) integrin and CXCR3-
dependent manner [19, 52].
The non-classical monocytes patrol the vasculature to clear the damaged
endothelial cells (ECs) for maintaining the integrity of endothelium, and thus the
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Figure 3.
Schematic representation of developmental stages of macrophages. HSCs, in the presence of TFs including PU.1
develop into CMP that further differentiates into promonocytes by undergoing different developmental stages.
The promonocytes in fetal liver develop into monocytes that further differentiate into macrophages. Whereas in
bone marrow promonocytes develop into Ly6C+ inflammatory monocytes also called classical monocytes.
However, in peripheral blood circulation they are further differentiated into Ly6C+ inflammatory monocytes
and Ly6C resident monocytes or non-classical monocytes residing in the blood and patrolling the vasculature.
On the other hand Ly6C+ inflammatory monocytes or classical monocytes migrate to different organs and
develop into different tissue/organ specific macrophages as described in the figure.
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vasculature during homeostasis and inflammatory conditions [53, 54]. Thus, these
Nr4a1-dependent non-classical monocytes serve as housekeepers for the endothelial
vasculature and orchestrate the necrosis by neutrophils due to damaged ECs induc-
ing the TLR7 signaling via in situ phagocytosis of cell debris derived from damaged
ECs [53]. Hence these non-classical monocytes play a crucial role in the pathogene-
sis of various diseases associated with vasculature along with the process of wound
healing and the resolution of the inflammation [54]. This patrolling nature of the
monocytes distinguishes them from macrophages as macrophages have a very lim-
ited capacity to emigrate from their site of location. In humans monocytes are
differentiated into two subsets on the basis of expression of surface expression of
CD14 and CD16 [55]. In humans the CD14++CD16monocytes are known as clas-
sical monocytes and are most prevalent monocyte subset in the blood [56, 57]. Like
mice Ly6chi monocytes they also express CCR2 [58]. The CD14+CD16+ monocytes
are considered as intermediate monocytes and CD14lowCD16+ monocytes are called
non-classical monocytes in humans [56].
The CD14lowCD16+monocytes in humans are similar to mice Ly6clowmonocytes
and patrol the vasculature or endothelium along with sensing the nucleic acids and
virus via TLR7 and TLR8 receptors [59]. These monocytes have weak phagocytic
potential and do not produce ROS and cytokines in response to cell-surface TLRs.
However they produce TNF-α, IL-1β, and CCL3 in response to viruses and immune
complexes containing nucleic acids due to the activation of TLR7 and TLR8 signal-
ing pathways [59]. Thus it can be inference that mice and human monocytes do not
precisely overlap in terms of their receptor expression including PPAR-γ (peroxi-
some proliferator-activated receptor-γ) that is signature for mouse monocytes but
absent in humans, however, the process of their differentiation and the function in
immune defense is apparently similar [60–62]. For example, approximately 270
genes in humans and 550 genes in mice monocytes (both types including classical or
non-classical one) are expressed differentially and more than 130 of these gene
expressions are conserved between mouse and human monocyte subsets [62]. Thus
this difference between human and mouse monocytes should be kept in mind when
developing and studying human diseases in mice.
The development of mononuclear phagocytes from monocyte/macrophage pro-
genitor cells is directed by colony stimulating factors (CSFs) including M-CSF,
granulocyte-monocyte colony-stimulating factor (GM-CSF), and fms-like tyrosine
kinase 3 ligand (Flt3-ligand) [63–65]. The number of various tissue and organ
monocytes/macrophages are regulated by M-CSF without any alteration in their
activation stage [64]. However, GM-CSF is involved in the activation of both
monocytes and macrophages along with its participation in the differentiation into
DCs. The mature cells developed during fetal development and later in life are
distributed accordingly as sinus-lining and interstitial resident macrophages in
lymphohematopoietic and other organs including lungs, liver, spleen, gut, skin and
brain. Major tissue-resident macrophages, including liver KCs, lung alveolar,
splenic, and peritoneal macrophages, are established prior to birth and their main-
tenance starts subsequently by themselves independent of replenishment of blood
monocytes during adulthood [47]. The macrophages present in endocrine and
reproductive organs including testes, adipose, vascular, musculoskeletal and con-
nective tissues are less well characterized.
3. Macrophage polarization
The polarization of macrophages gives a diverse heterogenic function and
phenotypes to them depending on their activation in respect to their duration of
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stimulation and spatial localization [66]. The macrophage polarization is not a fixed
process due the plasticity of the macrophages to integrate multiple signals (different
pathogens and their PAMPs, DMAPs, and normal tissue environment). Thus mac-
rophage polarization occurs in response to cell-cell interaction and cell-molecule
interaction within the host tissues or organs to maintain the homeostasis or during
different pathological conditions [67, 68]. Thus macrophage polarization is regu-
lated by at least three different mechanisms: (1) epigenetic and cell survival mech-
anisms, (2) external stimuli (pathogens, PAMPs, and allergens), and (3) tissue
environment including DAMPs [66]. The inflammation and associated immune
response is a good pathogenic condition to study the macrophage polarization as
this process impacts the inflammation from its initiation to the resolution phase.
The details of macrophage polarization are discussed elsewhere [66, 67, 69].
Depending on their polarization status the macrophages can be categorized in to
M0, M1 (classically activated macrophages (CAMs) or pro-inflammatory), and M2
(alternatively activated macrophages (AAMs) or anti-inflammatory) macrophages
(Figure 4). M0 macrophages can be considered as naïve macrophages that have not
been exposed to any pro- or anti-inflammatory stimuli or environment. M1 or
CAMs are developed when M0 macrophages are exposed to bacterial moieties
including LPS and Th1 cytokines including IFN-γ, IL-2, IL-12, IL-18 and TNF-β
(lymphotoxin β (LT-β)) etc., whereas M2 or AAMs are developed upon exposure to
Th2 cytokines including IL-4, IL-5, IL-6, and IL-10 [70, 71]. The M2 macrophages
can further be divided into M2a, M2b, and M2c depending on their stimulus for the
activation. The M2 macrophages induced by IL-4 or IL-13 are called M2a (a stands
for alternative), M2b macrophages are induced by poly I:C or TLR or IL-1R ago-
nists, and M2c are induced by IL-10 and glucocorticoids [72]. M2 macrophages
exhibit a higher phagocytic activity, higher expression of scavenging, mannose and
galactose receptors, produce higher concentration of ornithine and polyamines due
to high arginase pathway, secrete high amount of IL-10 and express higher levels of
the IL-1 decoy receptor and IL-1RA [40]. Thus, M2 macrophages in general exert an
anti-inflammatory action and play a crucial role in anti-parasitic immune response
required for parasite clearance, promote tissue remodeling, vasculogenesis, tumor
progression [70, 72, 73]. The M1 macrophages express Th1 cell-attracting
chemokines including CCL5 or regulated upon activation, normal T cells expressed,
and secreted (RANTES), CXCL9 and CXCL10, whereas M2 macrophages express
the chemokines CCL17, CCL22 and CCL24 [74].
The M1 macrophages highly express cyclo-oxygenase 2 (COX 2) enzyme,
inducible nitric oxide synthase (iNOS or NOS2) involved in nitric oxide (NO.)
synthesis, whereas M2 macrophages express COX 1 and arginase is expressed in
M2a and M2c required to synthesize ornithine and polyamines but not in M2b
macrophages activated by Poly I:C and LPS [72, 74, 75]. The metabolic process of
macrophages governing their pro-inflammatory and anti-inflammatory action also
differs in M1 and M2 macrophages. M1 macrophages exhibit a shift from normal
oxidative phosphorylation (OXPHOS) to increased glycolysis, increased release of
lactate, a decreased oxygen consumption and glutaminolysis. On the other hand M2
macrophages are dependent on fatty acid oxidation (FAO) as a major source of
energy along with the mitochondrial OXPHOS. The detailed description of macro-
phage (both M1 and M2) immunometabolism is beyond the scope of the chapter
and described elsewhere [76, 77]. Succinate (a signaling metabolite) regulates the
macrophage polarization via succinate receptor 1 (SUCNR1) and regulates the pro-
cess of inflammation [78]. The myeloid-specific deficiency of SUCNR1 promotes a
local pro-inflammatory or M1 phenotype among macrophages, disrupts glucose
homeostasis in mice, exacerbates the metabolic effects of diet-induced obesity and
impairs the browning of the adipose-tissue under cold conditions [78]. On the other
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hand SUCNR1 via succinate binding stimulates the anti-inflammatory (M2) pheno-
type among macrophages as indicated by the release of type 2 or anti-inflammatory
cytokines including IL-4. Thus succinate exerts the anti-inflammatory action via
SUCNR1 on macrophages via controlling their polarization [78]. The macrophages
Figure 4.
Schematic representation of macrophage polarization. Naïve or M0 macrophages upon different stimulation as
describe in the figure and the text differentiate into pro-inflammatory M1 macrophages or classically activate
macrophages (CAMs) and anti-inflammatory macrophages called alternatively activated macrophages
(AAMs) or M2 macrophages. These M2 macrophages are further differentiated into M2a, M2b, and M2c
macrophages depending on the stimulus as mentioned in the figure and the text.
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involved in the resolution of inflammation are called resolution-phase macrophages
(rMs). The rMs differ from both M1 and M2 macrophages in terms that they have
weak bactericidal properties and express an alternatively activated phenotype along
with higher expression of markers of M1 macrophages (i.e. inducible cyclooxygen-
ase (COX 2) and nitric oxide synthase (iNOS)) [79]. This phenotype of rMs is
controlled by cyclic adenosine monophosphate (cAMP) as its inhibition converts
rMs into M1 macrophages [79]. On the other hand the upregulation of cAMP in M1
macrophages converts them in rMs. Although rMs are nonessential to clear neutro-
phils during self-limiting inflammation but are required for the initiation of post
resolution lymphocyte repopulation signaling event via COX 2 lipids. Thus, rMs are
the hybrid of both M1 and M2 macrophages and play an important role in the post
resolution innate-lymphocyte repopulation and the restoration of tissue/organ
homeostasis. Table 1 is showing the major differences between M1 and M2 macro-
phages. The detailed mechanism of macrophage polarization (M1 and M2), its
M1 macrophages M2 macrophages
1. Phenotype Express high levels of MHC-II, CD68,
and CD80 and CD86 costimulatory
molecules
Express higher levels of CD206,
CD200R, CD163 and transcription factor
called CMAF (musculoaponeurotic
fibrosarcoma) and response gene to
complement 32 (RGC-32)
2. Upregulated
genes
Suppressor of cytokine signaling 3
(SOCS3), iNOS or NOS2, Macrophage
receptor with collagenous structure
(Marco), Il12B, Il23a (Il23p19) and Ptgs2
(Cox2)
Arg1, MMR (Mrc1), resistin-like
molecule α (FIZZ1) or Relma or Retnla,
Ym1, Irf4, Cxcl12, Cxcl13, Ccl24 and
Klf4
3. Action Pro-inflammatory Anti-inflammatory
4. Cytokines and
chemokines
produced
IFN-γ, IL-8, TNF-α, IL-1β, RANTES
(CCL5), CXCL10
IL-13, IL-10, CCL17, CCL18, CCL22
5. Metabolic
pathway
Glycolysis and glutaminolysis FAO and OXPHOS
6. HIF-1α
expression
High Low
7. Inducers or
stimuli
IFN-γ, PAMPs (i.e. LPS), GM-CSF Glucocorticoids, IL-10, IL-4, IL-13 and
M-CSF
8. ROS and RNS
production
High ROS and NO. production Low ROS and NO. production
9. Rate of
acidification
Low High
10.
Antimicrobial
action
High Low
11. Glucose
uptake
Mainly depends on HIF-1α and Akt/
mTORC1 activation
Mainly depends on Akt/mTORC1
activation
12. Macrophage
galactase-type
C-type lectins
Low High
13. Autophagy Induce autophagy during tuberculosis
(TB) infection
Decrease autophagy during TB infection
Table 1.
Differences between M1 and M2 macrophages.
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regulation and impact on inflammatory process including in cancer are described
somewhere else [66, 70–73, 75, 80, 81].
4. Role of monocytes and macrophages in host defense
Macrophages are present in almost every tissue or organ system including the
barriers system comprising of respiratory tract (pulmonary alveolar and interstitial
macrophages), skin, gastrointestinal tract (GIT), and reproductive tract [82–91].
Thus their presence in the every organ system along with the mucosal sites serving
as potential sites for the entry of pathogens, toxins, allergens and xenobiotics makes
them first line of defense.
Monocytes/macrophages are one of the major innate immune cells involved in
the process of recognition of pathogens and the cell debris originated as a result of
apoptosis and their engulfment by the process of phagocytosis. Thus along with
other innate immune cells including neutrophils, dendritic cells (DCs), mast cells,
monocytes, and macrophages are considered as ‘professional’ phagocytes. The pro-
fessional phagocytes are differentiated from non-professional phagocytes on the
basis of their effectiveness in mediating the phagocytosis [92]. The major factor
contributing to the effectiveness of the phagocytosis and characteristic of profes-
sional phagocytes is the expression of various receptors on their cell surface
involved in the recognition of molecules or ligands that are not normally expressed
by normal and healthy cells [93]. For example, scavenger receptors (SRs) play
important role in the recognition and binding of apoptotic and necrotic cells,
opsonized pathogens (i.e. pathogens opsonized by complement protein C5a and
C3a), and cell debris. The scavenger receptor-A1 (SR-A1)-mediated phagocytosis of
low density lipids (LDLs) or oxidized lipids causes the formation of foam cells and
this phenomenon is involved in the pathogenesis of atherosclerosis [94]. The
absence of SR-A1 in macrophages increase their pro-inflammatory action due to the
increased p42/44 mitogen-activated protein kinase (MAPK) phosphorylation,
interferon regulatory factor-3 (IRF-3) and NF-κB nuclear translocation and
increased production and secretion of TNFα, IL-6 and IFN-β due to the increased
activation of TLR4 signaling pathway [95]. Thus SR-A1 antagonizes the TLR4-
mediated phagocytosis and pro-inflammatory immune response of macrophages in
the presence of LPS and gram-negative bacteria in a competitive manner [95].
Additionally, alveolar macrophages expressing SR-A1 and class A scavenger
receptors (SRAs) called macrophage receptor with collagenous structure (MARCO)
protect the host from inhaled toxicant and pathogens by phagocytosing the oxidized
lipids and decreasing the inflammatory damage [96]. The detailed information of
scavenger receptors is beyond the scope of the chapter and is described elsewhere
[97–101]. In addition, professional phagocytes including monocytes and macro-
phages express various Toll-like receptors (TLRs) [93]. However the interplay
between phagocytic receptors (which initiate and assist in the mechanics of phago-
cytosis) and pattern recognition receptors (PRRs, such as TLRs, which detect
PAMPs or DAMPs) is complex. The interplay between these receptors may involve
both synergistic and antagonistic interactions, including downstream signaling
mechanisms within the phagocytic cell that remain largely unknown [102, 103].
During and following phagocytosis, PRRs (including TLRs, C-type lectin recep-
tors (CLRs), scavenger receptors, retinoic acid-inducible gene 1 (RIG1)-like
helicase receptors (RLRs) and NOD-like receptors (NLRs)) recognize different
PAMPs and DAMPs along with different xenobiotics including silica or asbestos
[104, 105]. Some PRRs including mannose receptor, DC-specific ICAM3-grabbing
non-integrin (DC-SIGN) and MARCO are also involved in the process of pathogen
10
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recognition and phagocytosis, whereas signaling PRRs (which include the TLRs,
NLRs and RLRs) sense microbial products and aberrant self-molecules on the cell
surface or in the cytoplasm of cells and activate transcriptional mechanisms that
lead to phagocytosis, cellular activation and the release of cytokines, chemokines
and growth factors [106–109]. During phagocytosis of the pathogens, the TLR2
recruits into the phagosome and discriminates between pathogens along with
initiating the pro-inflammatory immune response [110]. The TLR-induced phago-
cytosis of bacteria is reliant on MyD-88-dependent signaling via interleukin-1
receptor-associated kinase-4 (IRAK-4) and p38 MAP kinase causing an up-
regulation of SRs [111]. TLR9 is the strongest inducer of phagocytosis among all the
TLRs, whereas TLR3 is the weakest inducer of the process [111]. However, TLR4-
stimulated phagocytosis also requires the activation of MyD-88-independent actin-
Cdc42/Rac pathway [112, 113].
Macrophages also express various complement receptors (CRIg, C1qR, CR3,
C5aR, C5L2 or C5bR, etc.) and Fc receptors on their cell surface that bind and
phagocytose the opsonized pathogens or other molecules and activate the comple-
ment system (CS)-mediated immune response for increasing the process of phago-
cytosis [114–116]. CRIg is a member of complement receptor of the
immunoglobulin superfamily that binds to complement fragments C3b and iC3b
opsonizing the pathogens to initiate their phagocytosis [115]. The expression of
CRIg on macrophages increases in the presence of dexamethasone and IL-10, but
decreases in the presence of IFN-γ, IL-4, TGF-β1, arachidonic acid (AA) [117]. AA
decreases the expression of CRIg on macrophages by activating the protein kinase
C (PKC) independent of its metabolism via cyclooxygenase and lipoxygenase path-
way [117]. The CR3-mediated phagocytosis of the pathogens is mediated by the
activation of Syk-kinase that becomes tyrosine-phosphorylated and accumulates
around the nascent phagosomes [114]. However, it also negatively regulates the
phagocytosis of degenerated myelin sheath by activating Syk-kinase and cofilin
(an actin-depolymerizing protein controlling F-actin remodeling) in microglia and
macrophages [118]. C1q component of the CS plays a crucial role in the process of
phagocytosis by triggering the rapid enhancement of the phagocytosis independent
of its role in direct activation of the classical complement pathway [119]. The
engulfment of the membrane attack complex (MAC) deposited on pathogens by the
macrophages during the process of phagocytosis activates the NALP3 (NACHT,
LRR and PYD domains-containing protein 3 or cryopyrin) inflammasome via
inducing K+ efflux and ROS generation [120]. The NALP3 activation activates
caspase 1 (CASP1) to cause the maturation and release of IL-1β and IL-18 [120].
This also induces the differentiation of T cells into Th17 cells when these macro-
phages are used as antigen presenting cells (APCs). Thus, macrophages use various
surface receptors and secreted molecules to monitor and respond to changes in the
vicinity of their tissue environment.
5. Role of macrophages in homeostasis (angiogenesis, wound repair,
and regeneration) and diverse inflammatory conditions (metabolic
diseases and autoimmunity)
5.1 Macrophages in angiogenesis
Macrophages play a crucial role in the immune homeostasis via regulating the
process of inflammation under both sterile and infectious inflammatory conditions.
In addition to this they also play a crucial role in the process of angiogenesis
(Figure 5), metabolism, and salt and water balance [121]. For example, myeloid
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cells including monocytes and neutrophils are the first innate immune cells migrat-
ing through post capillary venules (PEVs) at the site of inflammation and tissue
injury or tissues requiring microvascular growth and remodeling including several
tumors due to the expression of CCR2 that binds to the chemokine called CCL2
[122, 123]. Furthermore an inhibition in the chemo-attraction and migration of
monocytes at the site of tissue ischemia causes a flap necrosis due to impaired
neovascularization [124]. Macrophages also synthesize, release, and respond (or
reprogram themselves) to various pro- and anti-angiogenic factors including vas-
cular endothelial growth factor-A (VEGF-A), and several angiopoietins including
angiopoietin (ANG) 1 and ANG 2 [125–127]. Thus these recruited monocytes or
tissue macrophages reprogram themselves in the presence of theses angiogenic
factors to serve as angiogenic and arteriogenic professional cells (APCs) [125]. For
example, ANG1 exerts its angiogenic action on macrophages via repressing the
expression of prolyl hydroxylase domain protein 2 (PHD2) through angiopoietin
(ANG)-TIE2 (angiopoietin-1 receptor or CD202B) signaling that supports their
reprograming into angiogenic and APCs [127, 128]. ANG2-dependent TIE2-signal-
ing in macrophages plays a crucial role in the induction of angiogenesis during
inflammation and tumor growth as both condition are associated with increased
hypoxia causing an induction of hypoxia inducible factors (HIFs) including HIF-1α
and HIF-2α enhancing the generation of tumor and angiogenesis promoting mole-
cules and cytokines (CXCR4, GLUT1 (glucose transporter 1), VEGF A, IL-1β, IL-8,
adrenomedullin, and ANG 2) [129–131].
These angiogenesis supportive macrophages exhibit the similarity with M2 mac-
rophages and in tumor environment they are called tumor-associated macrophages
Figure 5.
Macrophages play important role in host defense, immune homeostasis, regeneration, and inflammation. The
detailed mechanisms of macrophages impact on the processes mentioned in the figure are described in the text.
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(TAMs) with higher levels of IL-6, iNOS, and TIE2 [132]. These M2 macrophages
and TAMs support the growth, proliferation, and migration of endothelial cells
(ECs) and blood vessel formation or sprouting by releasing VEGF-A as well as
promoting the synthesis and release of VEGF-A and fibroblast growth factor-2
(FGF-2) or basic-FGF (b-FGF) from the tissue or tumor microenvironment cells
[133]. The TAM-mediated support of angiogenesis and tumor growth is determined
by TIMP-1 (tissue-inhibitor of matrix metalloproteinase-1) levels free of or
complexed with pro-MMP-9 (matrix metalloproteinase-9) [134]. For example,
MMP-9 null macrophages are non-angiogenic. In addition to secreting the angio-
genic factors, macrophages also interact with cells including pericytes, ECs, and
vascular smooth muscle cells for regulating angiogenesis observed during embry-
onic development, adult responses to injury, and in tumor microenvironment [135].
Furthermore the depletion of macrophages disrupts the process of vascular pat-
terning in response to insufficient vascular pruning due to decreased phagocytosis
of endothelial cells and pericytes during both embryonic and postnatal development
of organs [135–137].
5.2 Macrophages in wound repair
Macrophages also serve as crucial immune cells involved in the process of
wound repair in response to stimuli generated in the local tissue milieu [138, 139].
The phenomenon of wound repair is mainly regulated by AAMs or M2 macrophages
due to their anti-inflammatory action, induction of angiogenesis, and decreased
apoptosis that induces the extracellular matrix remodeling and the process of
wound repair and regeneration [138, 139]. These wound repair macrophages are
characterized by the higher production of various growth factors including platelet-
derived growth factor (PDGF), insulin-like growth factor-1 (IGF-1), transforming
growth factor-α (TGF-α), TGF-β, and VEGF-A causing angiogenesis and
supporting cell proliferation to alleviate the hypoxia caused by the inflammatory
tissue insult [140]. The TGF-β stimulates the differentiation of the local and
recruited tissue fibroblasts into myofibroblasts facilitating the contraction and clo-
sure of the wound area along with the synthesis of the extracellular matrix (ECM)
components [141]. Additionally macrophages also release amphiregulin (AREG)
that serves as an epidermal growth factor receptor ligand (EGFRL) to play a role in
the restoration of tissue homeostasis after injury or wound healing [142, 143]. The
wound healing or repair mechanism by AREG involves the release of TGF-β from
latent complexes via integrin-αV activation that induces the differentiation of mes-
enchymal stromal cells (pericytes) into myofibroblasts to restore the vascular bar-
rier function within injured tissue during the process of wound healing [142].
These wound repair macrophages also augment the proliferation and expansion
of many neighboring parenchymal and stromal cells along with activating stem cells
and local progenitor cells to participate actively in tissue repair response during
chronic or severe injury [144]. Hence, the disruption of monocyte recruitment and
the inhibition of local macrophages and their conversion into M2 or AAMs may
dampen the process of wound repair. For example, in some cases the disruption in
the process of wound repair may lead to the development of tissue or organ fibrosis
or scarring due to the overactivation of wound repair macrophages that can further
impair organ’s normal function causing ultimate organ failure and death of the
patient [145, 146]. For example, idiopathic pulmonary fibrosis (IPF), hepatic fibro-
sis and systemic sclerosis, are tightly regulated by ‘pro-fibrotic’ macrophages pro-
ducing PDGF, IGF-1, TGF-β1 (induces myofibroblast transdifferentiation and
promotes matrix accumulation), and directly activating fibroblasts [93, 147–150].
These pro-fibrotic macrophages also secrete pro-inflammatory cytokines including
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IL-1β that stimulates Th17 cells to secrete IL-17 involved in the bleomycin pulmo-
nary fibrosis, MMPs and TIMPs that regulate the inflammatory cell recruitment and
the ECM turnover [146, 151–154]. Hence macrophages are involved in the process
of wound repair and the impairment in their function may lead to the poor wound
healing and the development of fibrosis causing organ failure and the death of the
patient. Therefore targeting of the pulmonary macrophages and their mediators
play a crucial role in the process of pulmonary fibrosis [155].
5.3 Macrophages in regeneration
Macrophages also play a crucial role in the process of tissue and organ regener-
ation that refers to the process of proliferation of cells and tissues to replace the
damaged and lost structures [156]. The organs and tissues including skeletal mus-
cles and liver exhibit a higher degree of regenerative capacity through the regener-
ation of parenchymal cells involving monocytes and hepatocytes [157]. In most
tissues the complete regeneration of intact tissues is not achieved and results in the
formation of scar [158]. Macrophages play a very important role in the regeneration
process of skeletal muscle by coordinating the inflammation and regeneration [157].
They act as essential immune cells for the recovery of tissue integrity and function
following the injury [150]. The macrophages involved in the process of regeneration
of skeletal muscle are located in the interstitial space between myofibers, specifi-
cally in the perimysium (the connective tissue surrounding muscle fascicles), epi-
mysium, (the connective tissue surrounding the whole muscle), and perivascular
space that recruit circulating neutrophils and monocytes following the muscle
injury to initiate the process of inflammation [157]. The monocytes infiltrated into
the damaged skeletal muscle undergo the process of in situ transition to develop into
Ly6Chi (inflammatory) and Ly6Clow (regenerative or repair) macrophages that is
independent of NR4A1 (nuclear receptor subfamily 4 group Amember 1) or NUR77
or nerve growth factor IB (NGFIB) [159]. The NUR77 belongs to the family of the
Nur nuclear receptors acting as intracellular transcription factors and plays a crucial
role in the macrophage-mediated inflammatory immune response generation [160].
The transition of monocytes into Ly6Chi (inflammatory) and Ly6Clow (regenerative
or repair) macrophages plays a crucial role in the process of muscle regeneration
[161]. The Ly6Clow macrophages in the skeletal muscle exhibit a distinct pro-
resolving signature [specialized pro-resolving lipid mediators (SPMs), including
resolvins (for example, RvD1, RvD2, RvE1)] that helps in the functional improve-
ment in the process of muscle regeneration [162]. On the other hand Ly6Chi
inflammatory monocytes further differentiate into skeletal tissue macrophages
(both M1 and M2) and secrete pro-inflammatory cytokines (i.e. FN-γ, TNF-α, IL-
1β, and IL-6) that are also integral component of myogenic precursor cells (MPCs)
or myoblasts. The M2 macrophages on the other hand promote the differentiation
and maturation of MPCs [157, 163, 164]. In addition macrophages are also shown to
involve in the process of regeneration of heart/cardiomyocytes in different animals
(Zebra fish, Salamander, and the laboratory mouse) [165–167]. Even studies have
also shown the involvement of macrophages in the regeneration of spinal cord and
tail fin of Zebra fish [168, 169]. Wnt signaling in macrophages plays a critical role in
driving parenchymal regeneration in animal models of liver injury [170]. After the
death of hepatocytes phagocytic uptake of the cell debris by macrophages synthe-
sizes Wnt3a that in nearby hepatic progenitor cells (HPCs) induces the canonical
Wnt signaling cascade facilitating their specification to hepatocytes [171]. Even the
regeneration of hair follicles also involves the macrophage-mediated key signals to
local stem cells facilitating the regeneration of hair follicles upon plucking of hairs
[172]. The plucking of hairs causes the local generation of CCL2 that promotes
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pro-inflammatory TNF-α generating macrophages and initiates the process of hair-
follicle regeneration [172]. Thus the fine tuning of macrophages is essential for their
protective function during would healing or repair, regeneration or the induction of
fibrosis due to the loss of this fine tuning leading to the organ damage and failure.
5.4 Macrophages in autoinflammation and autoimmunity
The uncontrolled activation of macrophages in response to DAMPs recognized by
various PRRs and apoptotic cells (uncontrolled phagocytosis) may lead to chronic and
uncontrolled inflammation that may induce autoinflammation and autoimmune dis-
eases including severe autoimmune anemia, systemic lupus erythematosus (SLE),
and chronic arthritis [173–176]. The increased infiltration of macrophages into the
brain (i.e., in meninges surrounding the CNS, the perivascular space, and the choroid
plexus) is also reported in experimental autoimmune encephalitis (EAE), an animal
model for multiple sclerosis (MS) [177, 178]. The chronic up-regulation of CCR2,
CCL2, CCL3, CCL4, and CCL22 stimulates the process of macrophage accumulation
at the sites of the brain affected during EAE [179, 180]. Both M1 andM2macrophages
play a crucial role in the pathogenesis of EAE orMS [180, 181]. Macrophages also play
a very important role in the pathogenesis of rheumatoid arthritis (RA) by secreting
various pro-inflammatory cytokines, controlling the generation and function of reg-
ulatory T cells (Tregs) via binding and release of transforming growth factor-β (TGF-
β), and their therapeutic targeting proves beneficial to the patients [182–185].
Sjogren’s syndrome (SS), a chronic autoimmune disease of exocrine glands specifi-
cally salivary glands and lacrimal glands causing also systemic autoimmune lesions
also shows the accumulation of monocytes and macrophages in the inflamed lesions
[185–187]. In addition to these autoimmune diseases, both M1 and M2 macrophages
also play a crucial role in the pathogenesis of type 1 diabetes mellitus by contributing
to the destruction of β cells of the pancreas through controlling the generation of Th1
cells and acting as antigen presenting cells (APCs) to stimulate cytotoxic CD8+ T cells
(T1DM) [188–190].
5.5 Macrophages in metabolic diseases
Obesity is an altered stage of metabolism originating due to the increased avail-
ability of nutrients (except in the genetically impaired conditions causing the depo-
sition of the white adipose tissue (WAT)) [191]. However, both obesity caused by
the genetic factors or due to the increased food intake and sedentary life style cause
a low-grade systemic chronic inflammation that may lead to the development of
type 2 diabetes mellitus (T2DM) and atherosclerosis [192–194]. The death of adi-
pocyte serves as a major trigger for the recruitment of inflammatory LY6ChiCCR2+
monocytes and the accumulation of macrophages in the WAT as more than 90% of
the macrophages in WAT are localized to the dead adipocytes [195, 196]. These
macrophages then fuse to form syncytia sequestering and scavenging the residual
“free” adipocyte lipid droplets and ultimately forming the multinucleate giant cells
that serve as a hallmark of chronic inflammation. Furthermore, these macrophages
recognize fatty acids (FAs) as potential inflammogens and reprogram themselves
into classical macrophages (M1 macrophages) during obesity [104, 197, 198]. For
example, saturated but not unsaturated fatty acids promote the inflammatory acti-
vation of macrophages via the activation of TLR4 as TLR4 is essential for high-fat
diet-induced insulin resistance in adipose tissue and liver [199–203]. Additionally,
Fetuin A (FetA or AHSG, a secreted glycoprotein) serves as an endogenous ligand
for TLR4 for promoting the lipid-induced insulin resistance, lipotoxicity in β cells of
the pancreas, and T2DM [204, 205]. However, M2 macrophages generated in the
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environment promote the health of the WAT and the insulin sensitivity by an
unknown mechanism in a lean state [206]. It can be hypothesized that the M2
macrophages via maintaining the health of adipocytes in WAT prevent the genera-
tion of signals including the death of adipose tissue that chemo-attract the pro-
inflammatory monocytes reprogramming later into classical M1 macrophages. The
genetic depletion of the M2 gene or M2 macrophages cause the induction of meta-
bolic diseases upon high-fat-diet [206]. IL-6 promotes the generation of AAMs or
M2 macrophages in adipose tissue environment during obesity [207]. The depletion
of CD11b also increases the number of AAMs in adipose tissue during obesity and
prevents the development of obesity-induced insulin resistance [208]. Thus
targeting CD11b during obesity may prevent obesity-induced insulin resistance.
Recently, a population of sympathetic neuron-associated macrophages (SAMs) has
been identified controlling the obesity by engulfing and clearing norepinephrine
(NE) [209].
6. Conclusion and future perspective
Macrophages are innate immune cells that serve as a first line of defense against
invading pathogens almost in every organ system including lungs, liver, intestine,
kidneys, and brain. Along with acting as first line of defense against pathogens,
PAMPs, DAMPs, and other xenobiotics they act as antigen presenting cells (APCs)
and provide processed antigens to activate the adaptive immune response compris-
ing of B and T cells. Thus macrophages are sentinel innate immune cells taking part
in the generation of both acute and chronic inflammation induced during both
sterile and infectious tissue damaging conditions via controlling the migration and
activation of other innate immune cells including neutrophils and dendritic cells
(DCs) as well as cells of the adaptive immune system. In addition to their role in
controlling the process of inflammation they are also involved in the process of
wound repair and regeneration, autoimmunity, obesity and associated insulin tol-
erance, angiogenesis and embryonic development of the fetus. Thus macrophage
are the potent immunoregulatory cells of the innate immune system involved in
host defense against infections and other inflammatory diseases including cancer
and autoimmunity along with the maintenance of immune homeostasis involving
the process of resolution phase during inflammation [210–212]. Hence macrophages
are very important innate immune cells with immune regulatory function
depending on their fine tuning or polarization during diverse inflammatory condi-
tions as described here in the chapter.
Although macrophages have been discovered a century ago and revolutionized
the immunology research and opened the road to the branch of immunology called
innate immunity but much more is still remaining to explore in macrophage biology
and their role in the regulation of development, homeostasis, immune homeostasis,
inflammation, and disease pathogenesis. For example, macrophage immunome-
tabolism and epigenetic mechanisms regulating their polarization and pro-and anti-
inflammatory phenotype and action have started to answer the several previously
unknown questions that may influence the future immunotherapeutics and immu-
nomodulatory approaches to target several immune-based diseases varying from
autoimmune diseases to several cancers to metabolic diseases.
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